Conigliaro, who owns a home in Southborough, has not returned calls for comment. Neither has Cadden, who owns property in Wrentham.
Pasedis, the Ameridose executive and pharmacy board member, declined comment Tuesday night through a woman who answered the door of her Quincy home and identified herself as Pasedis’s daughter.
US Representative Edward J. Markey, a Malden Democrat, said he will introduce legislation to strengthen the oversight of compounding pharmacies. The legislation will require certain pharmacies that engage in interstate commerce to register with the Food and Drug Administration and comply with basic minimum safety standards, among other things.
“These compounding pharmacies are operating as factories, mass producing and packaging specialized new drugs in large quantities and then sending them over state lines,” said Markey, senior member of the Energy and Commerce Committee, which has jurisdiction over the FDA.
The CDC has said hospitals and doctors should contact patients who received injections for low back pain using methylprednisolone acetate (80mg/ml) made by New England Compounding.
The agency moved back the time frame that caregivers began giving the potentially contaminated injections to May 21, 2012. The CDC previously said the injections began in July and were recalled Sept. 26, which means that additional infections, which can take up to four weeks to appear, may continue mounting until Oct 26.